Patent Assignment
Reel/Frame 057930/0118
Assignment of Assignor's Interest
Recorded: 2021-10-27
Pages: 3
Assignee
SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
ROOM 316, NO. 6 BUILDING, NO. 333 GUIPING ROAD, XUHUI DISTRICT, SHANGHAI, 200233, CHINA
Covered Property
(1)
Tumor-Specific Anti-Egfr Antibody and Application Thereof
Application:
17/182,956 →
Publication:
US 2022/0017625
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 27, 2021
From: SHANGHAI YIJIE BIOTECHNOLOGY CO. LTD
To: CARSGEN THERAPEUTICS CO., LTD.
Reel/Frame 057931/0333 →
Assignment of Assignor's Interest
Oct 27, 2021
From: CARSGEN THERAPEUTICS CO., LTD.
To: CAFA THERAPEUTICS LIMITED
Reel/Frame 057933/0603 →
Assignment of Assignor's Interest
Jun 15, 2022
From: CAFA THERAPEUTICS LIMITED
To: CRAGE MEDICAL CO., LIMITED
Reel/Frame 060208/0935 →